OM · Outset Medical, Inc.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Cap structure and valuation

Cap structure
SP	$4.12
SO	18.8M
Options	0.1M
Warrants	0.4M
FD SO	19.3M
MC	$79.4M

Cash	$35.0M
Total debt	$99.4M
EV	$143.8M

TTM Multiples
EV / Revenue	1.2x
EV / EBITDA	—
MC / Net Income	—
EV / FCF	—
MC / FCF	—

Ownership & coverage
Institutional	73.9%
Insiders	5.5%
# Institutions	123
Analysts	3
Consensus	Buy
Avg target	$7.67

Short % float	6.4%
Days to cover	6.48

MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-08-04. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-10-06 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-09-15; the float denominator can be unreliable on tiny floats.

Financial statements

	6/30/26	3/31/26	12/31/25	9/30/25
Total Revenue	31.64	27.86	28.87	29.43
Revenue YoY %	0.7%	(6.3%)	(2.0%)	2.7%
Cost of Revenue	18.35	15.77	16.64	17.84
Gross Profit	13.28	12.10	12.23	11.59
Gross Profit YoY %	11.9%	9.3%	13.8%	18.0%
Gross Margin %	42.0%	43.4%	42.4%	39.4%

SG&A	23.51	23.40	24.80	22.03
R&D	5.45	5.62	5.05	5.38
Operating Expense	28.96	29.01	29.86	27.40

Operating Income	(15.68)	(16.92)	(17.63)	(15.81)
Operating Income YoY %	7.1%	(3.2%)	19.4%	33.7%
Operating Margin %	(49.6%)	(60.7%)	(61.1%)	(53.7%)
EBITDA	(15.05)	(16.12)	(16.75)	(14.80)
EBITDA Margin %	(47.6%)	(57.9%)	(58.0%)	(50.3%)

Interest Expense	3.44	3.37	3.44	3.48
Other Income / (Expense)	1.35	1.53	1.67	1.85
Pretax Income	(17.76)	(18.76)	(19.40)	(17.43)
Tax Provision	0.22	0.22	0.10	0.40
Net Income	(17.98)	(18.98)	(19.49)	(17.84)
Net Margin %	(56.8%)	(68.1%)	(67.5%)	(60.6%)

Diluted EPS	-$0.97	-$1.03	-$1.00	-$1.00
Basic EPS	-$0.97	-$1.03	-$1.00	-$1.00
Diluted Avg Shares	18.6	18.4	—	17.8
Basic Avg Shares	18.6	18.4	—	17.8

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Total Revenue	117.80	119.48	113.69	130.38	115.38
Revenue YoY %	(1.4%)	5.1%	(12.8%)	13.0%	—
Cost of Revenue	68.61	72.72	75.12	101.38	97.54
Gross Profit	49.20	46.75	38.56	29.00	17.83
Gross Profit YoY %	5.2%	21.2%	33.0%	62.6%	—
Gross Margin %	41.8%	39.1%	33.9%	22.2%	15.5%

SG&A	93.74	92.22	113.54	141.46	130.00
R&D	21.50	21.23	38.40	57.31	48.85
Operating Expense	115.23	113.46	151.94	198.77	178.85

Operating Income	(66.04)	(66.71)	(113.38)	(169.77)	(161.02)
Operating Income YoY %	1.0%	41.2%	33.2%	(5.4%)	—
Operating Margin %	(56.1%)	(55.8%)	(99.7%)	(130.2%)	(139.6%)
EBITDA	(62.72)	(62.37)	(107.65)	(163.96)	(155.85)
EBITDA Margin %	(53.2%)	(52.2%)	(94.7%)	(125.8%)	(135.1%)

Interest Expense	13.73	13.95	23.87	12.68	3.57
Other Income / (Expense)	6.41	—	9.76	10.17	1.92
Pretax Income	(73.36)	(80.94)	(127.48)	(172.27)	(162.66)
Tax Provision	0.94	0.72	0.49	0.52	0.29
Net Income	(74.29)	(81.65)	(127.98)	(172.80)	(162.96)
Net Margin %	(63.1%)	(68.3%)	(112.6%)	(132.5%)	(141.2%)

Diluted EPS	-$4.00	-$5.37	-$36.96	-$52.28	-$3.38
Basic EPS	-$4.00	-$5.37	-$36.96	-$52.28	-$3.38
Diluted Avg Shares	18.6	15.2	3.5	3.3	48.2
Basic Avg Shares	18.6	15.2	3.5	3.3	48.2

	6/30/26	3/31/26	12/31/25	9/30/25
Cash & Equivalents	35.01	30.56	35.01	36.44
Short-term Investments	112.19	126.14	133.94	142.20
Receivables	29.22	25.32	28.33	32.96
Inventory	47.31	49.65	47.61	49.29
Other Current Assets	4.12	5.03	6.00	4.48
Total Current Assets	227.85	236.71	250.88	265.37

Net PPE	3.71	4.07	4.67	5.25
Operating Lease ROU	4.89	4.41	4.80	2.77
Other Assets	5.94	4.26	4.15	3.87
Total Assets	242.38	249.45	264.50	277.25

Accounts Payable	4.46	1.44	0.55	1.72
Current Lease Liabilities	2.04	1.79	1.74	1.91
Other Current Liabilities	37.40	34.37	35.34	33.81
Total Current Liabilities	43.89	37.61	37.63	37.45
Long-term Debt	97.65	96.94	96.24	95.52
Long-term Lease Liabilities	3.06	2.80	3.27	1.24
Other Liabilities	1.45	—	—	0.68
Total Liabilities	146.05	137.77	137.54	134.89

Retained Earnings	(1,208.34)	(1,190.35)	(1,171.38)	(1,151.88)
Total Equity	96.34	111.69	126.95	142.37

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Cash & Equivalents	35.01	35.01	124.01	68.51	73.22
Short-term Investments	112.19	133.94	34.67	134.81	214.28
Receivables	29.22	28.33	35.62	32.98	28.07
Inventory	47.31	47.61	59.39	49.22	51.48
Other Current Assets	4.12	6.00	4.53	5.70	6.60
Total Current Assets	227.85	250.88	258.22	291.22	373.64

Net PPE	3.71	4.67	8.13	13.27	15.88
Operating Lease ROU	4.89	4.80	3.94	5.38	6.12
Other Assets	5.94	4.15	5.50	3.93	4.48
Total Assets	242.38	264.50	275.80	313.80	400.12

Accounts Payable	4.46	0.55	3.86	5.83	0.60
Current Debt	—	—	—	—	4.75
Current Lease Liabilities	2.04	1.74	1.80	1.59	1.32
Other Current Liabilities	37.40	35.34	39.72	47.90	45.28
Total Current Liabilities	43.89	37.63	45.38	55.32	51.95
Long-term Debt	97.65	96.24	197.38	130.11	96.34
Long-term Lease Liabilities	3.06	3.27	2.68	4.48	5.58
Other Liabilities	1.45	—	3.54	1.00	—
Total Liabilities	146.05	137.54	248.98	190.91	154.12

Retained Earnings	(1,208.34)	(1,171.38)	(1,089.72)	(961.75)	(788.95)
Total Equity	96.34	126.95	26.82	122.89	245.99

	6/30/26	3/31/26	12/31/25	9/30/25
Net Income	(17.98)	(18.98)	(19.49)	(17.84)
D&A	0.63	0.80	0.88	1.01
Stock-Based Comp	2.70	3.45	4.06	5.08
Δ Working Cap & Other	5.03	1.89	5.03	5.43
Operating Cash Flow	(9.63)	(12.84)	(9.52)	(6.32)

CapEx	(0.11)	(0.07)	(0.22)	(0.16)
Other Investing	14.28	7.96	8.81	3.13
Investing Cash Flow	14.17	7.90	8.59	2.97

Debt Issuance	0.00	0.00	0.00	0.00
Other Financing	—	0.50	—	—
Financing Cash Flow	(0.09)	0.50	0.00	0.23

Free Cash Flow	(9.75)	(12.91)	(9.74)	(6.48)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Net Income	(74.29)	(81.65)	(127.98)	(172.80)	(162.96)
D&A	3.31	4.34	5.73	5.81	5.17
Stock-Based Comp	15.29	15.62	29.36	38.63	27.20
Δ Working Cap & Other	17.36	15.37	(23.41)	(3.02)	(15.14)
Operating Cash Flow	(38.32)	(46.33)	(116.30)	(131.37)	(145.73)

CapEx	(0.56)	(0.80)	(0.91)	(3.44)	(8.32)
Other Investing	34.18	(96.89)	104.85	86.47	(57.97)
Investing Cash Flow	33.62	(97.68)	103.94	83.03	(66.30)

Debt Issuance	0.00	98.27	66.52	33.23	96.06
Stock Issuance	—	—	—	0.00	0.00
Other Financing	0.64	(42.77)	1.35	10.43	(23.16)
Financing Cash Flow	0.64	55.50	67.87	43.65	72.90

Free Cash Flow	(38.88)	(47.12)	(117.22)	(134.81)	(154.05)

	6/30/26	3/31/26	12/31/25	9/30/25
Current Ratio	5.19	6.29	6.67	7.09
Quick Ratio	4.11	4.97	5.40	5.77
Debt / Equity	1.01	0.87	0.76	0.67
EBITDA Margin %	(47.6%)	(57.9%)	(58.0%)	(50.3%)
Working Capital	183.96	199.10	213.25	227.92
Net Debt	62.64	66.38	61.23	59.09
ROE %	(18.7%)	(17.0%)	(15.4%)	(12.5%)
ROA %	(7.4%)	(7.6%)	(7.4%)	(6.4%)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Current Ratio	5.19	6.67	5.69	5.26	7.19
Quick Ratio	4.11	5.40	4.38	4.37	6.20
Debt / Equity	—	—	—	—	0.41
EBITDA Margin %	(53.2%)	(52.2%)	(94.7%)	(125.8%)	(135.1%)
Working Capital	183.96	213.25	212.84	235.90	321.70
Net Debt	—	—	—	—	27.86
ROE %	(77.1%)	(64.3%)	(477.2%)	(140.6%)	(66.2%)
ROA %	(30.6%)	(30.9%)	(46.4%)	(55.1%)	(40.7%)

Insider activity (last 2 years)

Date Filed	Reporter	Relationship	Trans. Date	Code	Shares	Price	Total Value
2026-10-05	Leonard Braden Michael	10% Owner	2026-10-02	P	16,575	$3.88	$64,241
2026-10-05	Leonard Braden Michael	10% Owner	2026-10-01	P	228,334	$3.53	$806,019
2026-08-18	Trigg Leslie	Director, Officer (Chair and CEO)	2026-08-17	S	(3,437)	$4.39	-$15,088
2026-08-18	Brottem John L.	Officer (General Counsel)	2026-08-17	S	(2,632)	$4.39	-$11,554
2026-08-18	Gaeta Renee	Officer (Chief Financial Officer)	2026-08-17	S	(4,543)	$4.39	-$19,944
2026-06-29	Brottem John L.	Officer (General Counsel)	2026-06-26	A	59,830	—	$0
2026-06-29	Gaeta Renee	Officer (Chief Financial Officer)	2026-06-26	A	71,630	—	$0
2026-06-29	Trigg Leslie	Director, Officer (Chair and CEO)	2026-06-26	A	99,160	—	$0
2026-06-05	HACKETT PATRICK T	Director	2026-06-04	A	10,667	—	$0
2026-06-05	OBOYLE KEVIN C	Director	2026-06-04	A	10,667	—	$0
2026-06-05	Prange Karen	Director	2026-06-04	A	10,667	—	$0
2026-06-05	LANG BRENT D.	Director	2026-06-04	A	10,667	—	$0
2026-06-05	GROSSMAN D KEITH	Director	2026-06-04	A	10,667	—	$0
2026-06-05	Drexler Karen	Director	2026-06-04	A	10,667	—	$0
2026-06-05	Gaeta Renee	Officer (Chief Financial Officer)	2026-06-03	S	(17,672)	$4.94	-$87,300
2026-05-19	Trigg Leslie	Director, Officer (Chair and CEO)	2026-05-15	S	(3,445)	$3.70	-$12,746
2026-05-19	Nash Marc	Officer (EVP Operations R&D & Service)	2026-05-15	S	(1,582)	$3.70	-$5,853
2026-05-19	Brottem John L.	Officer (General Counsel)	2026-05-15	S	(2,638)	$3.70	-$9,761
2026-05-18	Leonard Braden Michael	10% Owner	2026-05-15	X	323,000	$5.00	$1,615,000
2026-05-12	Leonard Braden Michael	10% Owner	2026-05-11	X	96,900	$5.00	$484,500
2026-05-12	Leonard Braden Michael	10% Owner	2026-05-08	X	197,600	$5.00	$988,000
2026-04-08	Elliott Derick A.	Officer (EVP, Commercial)	2026-04-06	A	96,000	—	$0
2026-02-19	Brottem John L.	Officer (General Counsel)	2026-02-17	S	(2,842)	$3.35	-$9,521
2026-02-19	Trigg Leslie	Director, Officer (Chair and CEO)	2026-02-17	S	(3,361)	$3.35	-$11,259
2026-02-19	Nash Marc	Officer (EVP Operations R&D & Service)	2026-02-17	S	(1,817)	$3.35	-$6,087
2026-01-21	Nash Marc	Officer (EVP Operations R&D & Service)	2026-01-21	S	(980)	$4.98	-$4,880
2026-01-21	Brottem John L.	Officer (General Counsel)	2026-01-21	S	(1,180)	$5.01	-$5,912
2026-01-21	Trigg Leslie	Director, Officer (Chair and CEO)	2026-01-21	S	(2,120)	$5.05	-$10,706
2026-01-21	Nash Marc	Officer (EVP Operations R&D & Service)	2026-01-20	S	(5,375)	$5.12	-$27,520
2026-01-21	Brottem John L.	Officer (General Counsel)	2026-01-20	S	(9,314)	$5.12	-$47,688
2026-01-21	Trigg Leslie	Director, Officer (Chair and CEO)	2026-01-20	S	(11,794)	$5.12	-$60,385
2026-01-12	Prange Karen	Director	2026-01-09	A	18,667	—	$0
2026-01-08	Nash Marc	Officer (EVP Operations R&D & Service)	2026-01-07	S	(108)	$4.27	-$461
2026-01-08	Brottem John L.	Officer (General Counsel)	2026-01-07	S	(224)	$4.27	-$956
2026-01-08	Trigg Leslie	Director, Officer (Chair and CEO)	2026-01-07	S	(1,795)	$4.27	-$7,665
2025-12-02	Drexler Karen	Director	2025-12-01	S	(1,548)	$4.37	-$6,765
2025-11-18	Trigg Leslie	Director, Officer (Chair and CEO)	2025-11-17	S	(916)	$4.60	-$4,214
2025-11-18	Nash Marc	Officer (EVP Operations R&D & Service)	2025-11-17	S	(247)	$4.60	-$1,136
2025-11-18	Brottem John L.	Officer (General Counsel)	2025-11-17	S	(388)	$4.60	-$1,785
2025-08-25	Nash Marc	Officer (EVP, R&D, Operations and Serv.)	2025-08-25	A	5,617	—	$0
2025-08-18	Trigg Leslie	Director, Officer (Chair and CEO)	2025-08-15	S	(904)	$12.88	-$11,644
2025-08-18	Nash Marc	Officer (SVP Operations and R&D)	2025-08-15	S	(243)	$12.88	-$3,130
2025-08-18	Brottem John L.	Officer (General Counsel)	2025-08-15	S	(383)	$12.88	-$4,933
2025-06-11	Nash Marc	Officer (SVP Operations and R&D)	2025-06-10	A	29,676	—	$0
2025-06-11	Brottem John L.	Officer (General Counsel)	2025-06-10	A	35,993	—	$0
2025-06-11	Trigg Leslie	Director, Officer (Chair and CEO)	2025-06-10	A	65,103	—	$0
2025-06-11	Gaeta Renee	Officer (Chief Financial Officer)	2025-06-10	A	131,425	—	$0
2025-06-04	Saia Andrea Lynn	Director	2025-06-02	A	8,983	—	$0
2025-06-04	OBOYLE KEVIN C	Director	2025-06-02	A	8,983	—	$0
2025-06-04	LANG BRENT D.	Director	2025-06-02	A	8,983	—	$0
2025-06-04	HACKETT PATRICK T	Director	2025-06-02	A	8,983	—	$0
2025-06-04	GROSSMAN D KEITH	Director	2025-06-02	A	8,983	—	$0
2025-06-04	Drexler Karen	Director	2025-06-02	A	8,983	—	$0
2025-05-16	Trigg Leslie	Director, Officer (Chair and CEO)	2025-05-15	S	(935)	$17.80	-$16,643
2025-05-16	Nash Marc	Officer (SVP Operations and R&D)	2025-05-15	S	(252)	$17.82	-$4,491
2025-05-16	Brottem John L.	Officer (General Counsel)	2025-05-15	S	(396)	$17.82	-$7,057
2025-05-16	Ahmed Nabeel	Officer (Chief Financial Officer)	2025-05-15	S	(584)	$17.81	-$10,401
2025-05-14	OBOYLE KEVIN C	Director	2025-05-14	A	15,135	—	$0
2025-03-11	Trigg Leslie	Director, Officer (Chair and CEO)	2025-03-10	M	625,000	—	$0
2025-03-11	Trigg Leslie	Director, Officer (Chair and CEO)	2025-03-10	M	(2,500)	—	$-0
2025-03-11	LANG BRENT D.	Director	2025-03-10	M	250,000	—	$0
2025-03-11	LANG BRENT D.	Director	2025-03-10	M	(1,000)	—	$-0
2025-03-11	Drexler Karen	Director	2025-03-10	M	31,250	—	$0
2025-03-11	Drexler Karen	Director	2025-03-10	M	(125)	—	$-0
2025-03-11	GROSSMAN D KEITH	Director	2025-03-10	M	187,500	—	$0
2025-03-11	GROSSMAN D KEITH	Director	2025-03-10	M	(750)	—	$-0
2025-03-11	HACKETT PATRICK T	Director	2025-03-10	M	1,250,000	—	$0
2025-03-11	HACKETT PATRICK T	Director	2025-03-10	M	1,250,000	—	$0
2025-03-11	HACKETT PATRICK T	Director	2025-03-10	M	625,000	—	$0
2025-03-11	HACKETT PATRICK T	Director	2025-03-10	M	(5,000)	—	$-0
2025-03-11	HACKETT PATRICK T	Director	2025-03-10	M	(5,000)	—	$-0
2025-03-11	HACKETT PATRICK T	Director	2025-03-10	M	(2,500)	—	$-0
2025-03-11	Trigg Leslie	Director, Officer (Chair and CEO)	2025-03-07	A	2,500	$200.00	$500,000
2025-03-11	LANG BRENT D.	Director	2025-03-07	A	1,000	$200.00	$200,000
2025-03-11	Drexler Karen	Director	2025-03-07	A	125	$200.00	$25,000
2025-03-11	GROSSMAN D KEITH	Director	2025-03-07	A	750	$200.00	$150,000
2025-03-11	HACKETT PATRICK T	Director	2025-03-07	A	5,000	$200.00	$1,000,000
2025-03-11	HACKETT PATRICK T	Director	2025-03-07	A	5,000	$200.00	$1,000,000
2025-03-11	HACKETT PATRICK T	Director	2025-03-07	A	2,500	$200.00	$500,000
2025-02-19	Trigg Leslie	Director, Officer (Chair and CEO)	2025-02-18	S	(14,611)	$0.90	-$13,150
2025-02-19	Nash Marc	Officer (SVP Operations and R&D)	2025-02-18	S	(4,204)	$0.90	-$3,784
2025-02-19	Brottem John L.	Officer (General Counsel)	2025-02-18	S	(6,145)	$0.90	-$5,530
2025-02-19	Ahmed Nabeel	Officer (Chief Financial Officer)	2025-02-18	S	(8,659)	$0.90	-$7,793
2025-01-22	Trigg Leslie	Director, Officer (Chair and CEO)	2025-01-21	S	(4,403)	$0.80	-$3,522
2025-01-22	Trigg Leslie	Director, Officer (Chair and CEO)	2025-01-21	S	(42,384)	$0.80	-$33,907
2025-01-22	Trigg Leslie	Director, Officer (Chair and CEO)	2025-01-21	S	(18,449)	$0.80	-$14,759
2025-01-22	Nash Marc	Officer (SVP Operations and R&D)	2025-01-21	S	(356)	$0.80	-$285
2025-01-22	Nash Marc	Officer (SVP Operations and R&D)	2025-01-21	S	(21,590)	$0.80	-$17,272
2025-01-22	Nash Marc	Officer (SVP Operations and R&D)	2025-01-21	S	(971)	$0.80	-$777
2025-01-22	Nash Marc	Officer (SVP Operations and R&D)	2025-01-21	S	(304)	$0.80	-$243
2025-01-22	Brottem John L.	Officer (General Counsel)	2025-01-21	S	(777)	$0.80	-$622
2025-01-22	Brottem John L.	Officer (General Counsel)	2025-01-21	S	(29,474)	$0.80	-$23,579
2025-01-22	Brottem John L.	Officer (General Counsel)	2025-01-21	S	(2,679)	$0.80	-$2,143
2025-01-22	Ahmed Nabeel	Officer (Chief Financial Officer)	2025-01-21	S	(907)	$0.80	-$726
2025-01-22	Ahmed Nabeel	Officer (Chief Financial Officer)	2025-01-21	S	(29,474)	$0.80	-$23,579
2025-01-22	Ahmed Nabeel	Officer (Chief Financial Officer)	2025-01-21	S	(3,907)	$0.80	-$3,126
2025-01-22	Trigg Leslie	Director, Officer (Chair and CEO)	2025-01-17	A	99,419	—	$0
2025-01-22	Nash Marc	Officer (SVP Operations and R&D)	2025-01-17	A	4,494	—	$0
2025-01-22	Nash Marc	Officer (SVP Operations and R&D)	2025-01-17	A	1,404	—	$0
2025-01-22	Brottem John L.	Officer (General Counsel)	2025-01-17	A	9,090	—	$0
2025-01-22	Ahmed Nabeel	Officer (Chief Financial Officer)	2025-01-17	A	13,256	—	$0
2025-01-13	Trigg Leslie	Director, Officer (Chair and CEO)	2025-01-13	S	(33,227)	$0.81	-$26,914
2025-01-13	Nash Marc	Officer (SVP Operations and R&D)	2025-01-13	S	(15,011)	$0.81	-$12,159
2025-01-13	Brottem John L.	Officer (General Counsel)	2025-01-13	S	(20,492)	$0.81	-$16,599
2025-01-13	Ahmed Nabeel	Officer (Chief Financial Officer)	2025-01-13	S	(29,031)	$0.81	-$23,515
2025-01-07	Trigg Leslie	Director, Officer (Chair and CEO)	2025-01-07	S	(10,227)	$1.29	-$13,193
2025-01-07	Nash Marc	Officer (SVP Operations and R&D)	2025-01-07	S	(720)	$1.29	-$929
2025-01-07	Brottem John L.	Officer (General Counsel)	2025-01-07	S	(1,572)	$1.29	-$2,028
2025-01-07	Ahmed Nabeel	Officer (Chief Financial Officer)	2025-01-07	S	(1,835)	$1.29	-$2,367
2024-11-18	Trigg Leslie	Director, Officer (Chair and CEO)	2024-11-15	S	(5,645)	$0.80	-$4,516
2024-11-18	Nash Marc	Officer (SVP Operations and R&D)	2024-11-15	S	(1,375)	$0.80	-$1,100
2024-11-18	Brottem John L.	Officer (General Counsel)	2024-11-15	S	(3,203)	$0.80	-$2,562
2024-11-18	Ahmed Nabeel	Officer (Chief Financial Officer)	2024-11-15	S	(4,221)	$0.80	-$3,377